Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Volume

Perhaps it would help create yet another opportunity for Swartz to make a Kazillion percent profit on yet another loan? They better start being concerned about being too obvious

The recent Q filing stated they had suffient cash for al least the next twelve months, subsequent to which there have been new licensees and cash inflows.

Why on earth would they need a loan?

.

.

.

Be well

Share
New Message
Please login to post a reply